Literature DB >> 17211585

The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid.

Nobuyoshi Kitaichi1, Hiroko Matoba, Shigeaki Ohno.   

Abstract

PURPOSE AND METHODS: Activated T cells are believed to be important at the inflammatory sites in the pathogenesis of Vogt-Koyanagi-Harada disease. Patients are often affected by meningitis and uveitis. In this work, to examine the positive role of lumbar puncture in the diagnosis of VKH disease, we analyzed and compared the surface markers of aqueous humor cells, cerebrospinal fluid cells, and peripheral blood lymphocytes by use of flow cytometry.
RESULTS: Most lymphocytes were T cells. In aqueous humor and cerebrospinal fluid, numbers of CD3(+), CD4(+), and CD4(+)CD45RO(+) cells were significantly greater than in peripheral blood lymphocytes (P < 0.01). The CD4(+)/CD8(+) ratio for aqueous humor and cerebrospinal fluid was significantly higher than that for peripheral blood cells (P < 0.01). Four weeks after starting systemic corticosteroid treatment, numbers of CD4(+) and CD4(+)CD45RO(+) cells in cerebrospinal fluid were significantly lower than before treatment.
CONCLUSIONS: Profiles of surface markers were similar for cerebrospinal fluid and aqueous humor, but apparently different from that for peripheral blood cells. This suggests that cerebrospinal fluid may reflect the active local immunological reaction at sites affected by the disease, i.e. the uvea and the meninges.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211585     DOI: 10.1007/s10792-006-9016-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  13 in total

Review 1.  Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome.

Authors:  N A Rao
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

2.  Application of revised diagnostic criteria for vogt-koyanagi-harada disease in Japanese patients.

Authors:  Kunihiko Yamaki; Koji Hara; Shozo Sakuragi
Journal:  Jpn J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.447

3.  Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis.

Authors:  R W Read; N A Rao
Journal:  Ocul Immunol Inflamm       Date:  2000-12       Impact factor: 3.070

4.  Association between severity of inflammation in CNS and development of sunset glow fundus in Vogt-Koyanagi-Harada disease.

Authors:  Hiroshi Keino; Hiroshi Goto; Hideki Mori; Takuya Iwasaki; Masahiko Usui
Journal:  Am J Ophthalmol       Date:  2006-06       Impact factor: 5.258

5.  Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease.

Authors:  Isabelle Miyazawa; Toshiaki Abe; Koichi Narikawa; Juan Feng; Tatsuro Misu; Ichiro Nakashima; Juichi Fujimori; Makoto Tamai; Kazuo Fujihara; Yasuto Itoyama
Journal:  J Neuroimmunol       Date:  2005-01       Impact factor: 3.478

6.  Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Authors:  K Norose; A Yano
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

7.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.

Authors:  Francisco Max Damico; Edecio Cunha-Neto; Anna Carla Goldberg; Leo Kei Iwai; Maria Lucia Marin; Juergen Hammer; Jorge Kalil; Joyce Hisae Yamamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

9.  Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.

Authors:  N Kitaichi; S Kotake; Y Sasamoto; K Namba; A Matsuda; K Ogasawara; K Onoé; H Matsuda; J Nishihira
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

Review 10.  Macrophage migration inhibitory factor in uveitis.

Authors:  Satoshi Kotake; Nobuyoshi Kitaichi; Shigeaki Ohno
Journal:  Int Ophthalmol Clin       Date:  2002
View more
  2 in total

1.  Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease.

Authors:  Nobuyoshi Kitaichi; Yukihiro Horie; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-18       Impact factor: 3.117

2.  Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease.

Authors:  Yukihiro Horie; Wataru Saito; Nobuyoshi Kitaichi; Toshie Miura; Susumu Ishida; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.